NCT02918552View on ClinicalTrials.gov

Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

December 2, 2018

Study Completion Date

December 31, 2018

Conditions
Heart Failure
Interventions
DRUG

sodium nitrite

Subjects to receive active study drug three times daily during treatment period and then post treatment testing period.

DRUG

Control

Subjects randomized to placebo to receive three times daily during treatment period and then post treatment testing period.

Trial Locations (1)

15213

UPMC Montefiore Hospital, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Gladwin, Mark, MD

INDIV

NCT02918552 - Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter